The Benign Prostatic Hyperplasia and Its Aetiologies

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Health, Medicine and Nursing

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Update on AUA guideline on the management of benign prostatic hyperplasia.

  2011cited by this paper
• The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.

  2009cited by this paper
• Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms.

  2008cited by this paper
• Prostate growth and prevalence of prostate diseases in early onset spinal cord injuries.

  2008cited by this paper
• The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.

  2007cited by this paper
• Is benign prostatic hyperplasia (BPH) an immune inflammatory disease?

  2007cited by this paper
• Benign prostatic hyperplasia: an overview.

  2005cited by this paper
• Aetiology and pathogenesis of benign prostatic hyperplasia

  2003cited by this paper
• A review of guidelines on benign prostatic hyperplasia and lower urinary tract symptoms: are all guidelines the same?

  2003cited by this paper
• Hyperinsulinaemia as a Risk Factor for Developing Benign Prostatic Hyperplasia

  2001cited by this paper
• Apoptotic versus proliferative activities in human benign prostatic hyperplasia.

  1996cited by this paper
• THE AMERICAN UROLOGICAL ASSOCIATION SYMPTOM INDEX FOR BENIGN PROSTATIC HYPERPLASIA

  1992cited by this paper
• Correlation of the American Urological Association symptom index with self-administered versions of the Madsen-Iversen, Boyarsky and Maine Medical Assessment Program symptom indexes. Measurement Committee of the American Urological Association.

  1992cited by this paper
• Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal.

  1983cited by this paper

• No citing papers are available for this paper.